Nymox Pharmaceutical Corp
NYMXF- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001018735
No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Nymox Pharmaceutical Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- 0 vs. Q4 2022
- Shares held
- 1.69M
- +341.7K (+25.4%) vs. Q4 2022
- Total value
- $575.1K
- +$149.4K (+35.1%) vs. Q4 2022
- New holders
- 5
- 7 more added
- Sold out
- 5
- 8 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYMXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4.21K |
| Q1 2026 | 1 | $2.46K |
| Q4 2025 | 1 | $1.41K |
| Q3 2025 | 1 | $2.06K |
| Q2 2025 | 1 | $4.13K |
| Q1 2025 | 2 | $16.0K |
| Q4 2024 | 1 | $3.51K |
| Q3 2024 | 2 | $13.2K |
| Q2 2024 | 1 | $6.67K |
| Q1 2024 | 3 | $48.0K |
| Q4 2023 | 2 | $26.6K |
| Q3 2023 | 5 | $68.3K |
| Q2 2023 | 36 | $287.4K |
| Q1 2023 | 35 | $575.1K |
| Q4 2022 | 37 | $443.7K |
| Q3 2022 | 34 | $494.6K |
| Q2 2022 | 39 | $590.1K |
| Q1 2022 | 40 | $2.25M |
| Q4 2021 | 43 | $2.05M |
| Q3 2021 | 38 | $4.00M |
| Q2 2021 | 51 | $4.03M |
| Q1 2021 | 59 | $13.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Nymox Pharmaceutical Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steward Financial Group LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 636 | $0 | 0.00% | +636 | New |
| UBS Group AG | 375 | $128 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 708 | $240 | 0.00% | +354+100.0% | Added |
| BNP Paribas Arbitrage, SA | 859 | $292 | 0.00% | −344−28.6% | Reduced |
| Belpointe Asset Management LLC | 2,221 | $755 | 0.00% | +2,221 | New |
| Wells Fargo & Company | 3,296 | $1.12K | 0.00% | +200+6.5% | Added |
| BDO Wealth Advisors, LLC | 4,700 | $1.60K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 5,240 | $1.78K | 0.00% | +300+6.1% | Added |
| JPMorgan Chase & Co | 7,744 | $3.00K | 0.00% | −1,611−17.2% | Reduced |
| Cubic Asset Management, LLC | 10,000 | $3.40K | 0.00% | −4,000−28.6% | Reduced |
| Great Valley Advisor Group, Inc. | 10,000 | $3.40K | 0.00% | 00.0% | Unchanged |
| One Day In July LLC | 10,000 | $3.40K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 11,532 | $3.92K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 13,324 | $5.00K | 0.00% | −6,322−32.2% | Reduced |
| National Bank of Canada | 17,200 | $5.85K | 0.00% | 00.0% | Unchanged |
| WMS Partners, LLC | 18,000 | $6.12K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 19,984 | $6.79K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 20,400 | $6.94K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 21,322 | $7.25K | 0.00% | +1,250+6.2% | Added |
| Beaird Harris Wealth Management, LLC | 24,400 | $8.30K | 0.00% | 00.0% | Unchanged |
| CI Private Wealth, LLC | 25,000 | $8.50K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 28,000 | $9.52K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 39,621 | $13.5K | 0.00% | −10,077−20.3% | Reduced |
| Millennium Management LLC | 47,916 | $16.0K | 0.00% | +47,916 | New |
| Geode Capital Management, LLC | 50,678 | $17.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 60,306 | $20.5K | 0.00% | −23,858−28.3% | Reduced |
| Renaissance Technologies LLC | 69,381 | $24.0K | 0.00% | −13,419−16.2% | Reduced |
| Bleakley Financial Group, LLC | 80,000 | $27.2K | 0.00% | 00.0% | Unchanged |
| Sawtooth Solutions, LLC | 80,000 | $27.2K | 0.00% | +80,000 | New |
| Morgan Stanley | 98,686 | $33.6K | 0.00% | +1,068+1.1% | Added |
| Cetera Advisor Networks LLC | 118,900 | $40.4K | 0.00% | +51,775+77.1% | Added |
| BlackRock Inc. | 135,612 | $46.1K | 0.00% | +3,918+3.0% | Added |
| Corrigan Financial, Inc. | 302,252 | $102.8K | 0.03% | +302,252 | New |
| Federation des caisses Desjardins du Quebec | 351,000 | $119.3K | 0.00% | −29,800−7.8% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −25,126−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −19,900−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −7,490−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| PSI Advisors, LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| First Citizens Financial Corp | – | – | – | – | Not filed |
| Gofen & Glossberg LLC | – | – | – | – | Not filed |